318 related articles for article (PubMed ID: 30477390)
1. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
2. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
Perrier J; Viard A; Levy C; Morel N; Allouache D; Noal S; Joly F; Eustache F; Giffard B
Brain Imaging Behav; 2020 Feb; 14(1):226-241. PubMed ID: 30406352
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
5. Intraindividual variability in reaction time before and after neoadjuvant chemotherapy in women diagnosed with breast cancer.
Yao C; Rich JB; Tirona K; Bernstein LJ
Psychooncology; 2017 Dec; 26(12):2261-2268. PubMed ID: 28002893
[TBL] [Abstract][Full Text] [Related]
6. Predicting Patient Reported Outcomes of Cognitive Function Using Connectome-Based Predictive Modeling in Breast Cancer.
Henneghan AM; Gibbons C; Harrison RA; Edwards ML; Rao V; Blayney DW; Palesh O; Kesler SR
Brain Topogr; 2020 Jan; 33(1):135-142. PubMed ID: 31745689
[TBL] [Abstract][Full Text] [Related]
7. Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study.
Cerulla N; Arcusa À; Navarro JB; Garolera M; Enero C; Chico G; Fernández-Morales L
Breast Cancer Res Treat; 2017 Jul; 164(1):179-187. PubMed ID: 28421379
[TBL] [Abstract][Full Text] [Related]
8. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
9. Verbal fluency in breast cancer patients treated with chemotherapy.
Andryszak P; Wiłkość M; Żurawski B; Izdebski P
Breast Cancer; 2017 May; 24(3):376-383. PubMed ID: 27435227
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
Park JH; Bae SH; Jung YS; Jung YM
J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
[TBL] [Abstract][Full Text] [Related]
11. Pupillary response: cognitive effort for breast cancer survivors.
Myers JS; Kahya M; Mitchell M; Dai J; He J; Moon S; Hamilton K; Valla M; O'Dea A; Klemp J; Kurylo M; Akinwuntan A; Devos H
Support Care Cancer; 2019 Mar; 27(3):1121-1128. PubMed ID: 30097791
[TBL] [Abstract][Full Text] [Related]
12. Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review.
Yao C; Bernstein LJ; Rich JB
Breast Cancer Res Treat; 2017 Nov; 166(1):15-28. PubMed ID: 28707202
[TBL] [Abstract][Full Text] [Related]
13. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.
Jansen CE; Cooper BA; Dodd MJ; Miaskowski CA
Support Care Cancer; 2011 Oct; 19(10):1647-56. PubMed ID: 20820813
[TBL] [Abstract][Full Text] [Related]
14. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
[TBL] [Abstract][Full Text] [Related]
15. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K
Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951
[TBL] [Abstract][Full Text] [Related]
16. Long-term cognitive impairment of breast cancer patients after chemotherapy: A functional MRI study.
Miao H; Li J; Hu S; He X; Partridge SC; Ren J; Bian Y; Yu Y; Qiu B
Eur J Radiol; 2016 Jun; 85(6):1053-7. PubMed ID: 27161051
[TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
18. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints.
Deprez S; Vandenbulcke M; Peeters R; Emsell L; Smeets A; Christiaens MR; Amant F; Sunaert S
J Clin Oncol; 2014 Jul; 32(19):2031-8. PubMed ID: 24868029
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
